Evidence map›Paper›PMID 17320137›Full record

ArticleVirology2007

Investigating the human immunodeficiency virus type 1-infected monocyte-derived macrophage secretome.

Pawel Ciborowski, Irena Kadiu, Wojciech Rozek, Lynette Smith, Kristen Bernhardt, Melissa Fladseth, Mary Ricardo-Dukelow, Howard E Gendelman

Abstract read
In one paragraph

Article in Virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. MASS SPECTROMETRY IN VIROLOGICAL SCIENCES.Mass spectrometry reviews · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Proteomics, biomarkers, and HIV-1: A current perspective.Proteomics. Clinical applications · 2016
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pawel CiborowskiCenter for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198-5800, USA. pciborowski@unmc.edu
Irena Kadiu
Wojciech Rozek
Lynette Smith
Kristen Bernhardt
Melissa Fladseth
Mary Ricardo-Dukelow
Howard E Gendelman

Funding

VIRAL SHUTOFF OF HOST TRANSCRIPTION--PBCV-1 INFECTEDP20RR015635 · NCRR · UNIVERSITY OF NEBRASKA LINCOLN · PI WOOD, CHARLES · 2000 to 2009
$22.1M
Targeted Neuro Protection of HIV-1 Associated Neurologic DiseaseP01MH064570 · NIMH · UNIVERSITY OF ROCHESTER · PI GELBARD, HARRIS A · 2001 to 2014
$19.4M
Neuroprotective Immunity and HIV DementiaR01NS034239 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Howard E Gendelman, R Lee Mosley · 1995 to 2026
$12.3M
Proteomics CoreP01NS043985 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI ZHENG, JIALIN CHARLES · 2003 to 2012
$11.8M
Role of EAAT2 and AEG-1 in Astrocyte Dysfunction and NeurodegenerationP01NS031492 · NINDS · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI GELBARD, HARRIS A · 1993 to 2007
$10.9M
REGULATION OF TENSIONP01NS011766 · NINDS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI HIRANO, MICHIO · 1985 to 2007
$9.1M
Blood Brain Barrier Physiology and HIV DementiaR37NS036126 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E. · 2001 to 2007
$2.7M
Macrophage Protein Fingerprints in HIV-1 DementiaR21MH075662 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI CIBOROWSKI, PAWEL S · 2005 to 2006
$400k
NCRR NIH HHS 20 RR15635NCRR NIH HHS P20 RR015635NIMH NIH HHS 1R21 MH075662-01NIMH NIH HHS 5 R01 MH64570-03NIMH NIH HHS P01 MH064570NIMH NIH HHS R21 MH075662NINDS NIH HHS 1 P01 NS43985-01A1NINDS NIH HHS 5 P01NS31492-11NINDS NIH HHS 5 R01 NS034239-10NINDS NIH HHS 5 R37 NS36126-07NINDS NIH HHS P01 NS011766NINDS NIH HHS P01 NS031492NINDS NIH HHS P01 NS043985NINDS NIH HHS P01 NS11766-28NINDS NIH HHS R01 NS034239NINDS NIH HHS R37 NS036126
6 · The paper itself

Abstract

Mononuclear phagocytes (bone marrow monocyte-derived macrophages, alveolar macrophages, perivascular macrophages, and microglia) are reservoirs and vehicles of dissemination for the human immunodeficiency virus type-1 (HIV-1). How virus alters mononuclear phagocyte immunoregulatory activities to complete its life cycle and influence disease is incompletely understood. In attempts to better understanding the influence of virus on macrophage functions, we used one-dimensional electrophoresis, and liquid chromatography tandem mass spectrometry to analyze the secretome of HIV-1-infected human monocyte-derived macrophages. We identified 110 proteins in culture supernatants of control (uninfected) and virus-infected cells. Differentially expressed cytoskeletal, enzymes, redox, and immunoregulatory protein classes were discovered and validated by Western blot tests. These included, but were not limited to, cystatin C, cystatin B, chitinase 3-like 1 protein, cofilin-1, l-plastin, superoxide dismutase, leukotriene A(4) hydrolase, and alpha-enolase. This study, using a unique proteomics platform, provides novel insights into virus-host cell interactions that likely affect the functional role of macrophages in HIV disease.

Indexed as

Blotting, WesternCells, CulturedElectrophoresis, Polyacrylamide GelGene Expression RegulationHIV-1HumansMacrophagesMonocytesProteinsSpectrometry, Mass, Electrospray IonizationTime FactorsProteins

Identifiers

PMID17320137
PMCPMC1993545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.